S.R.I.W.

Santero Therapeutics is focused on developing innovative antibiotics aimed at addressing the challenges posed by multi-drug-resistant pathogens. The company creates medications that employ novel mechanisms of action to effectively combat infections resistant to traditional treatments. By providing therapies that maintain prolonged efficacy, Santero aims to improve patient outcomes and offer better-tolerated options for those afflicted with difficult-to-treat infections. Through its research and development efforts, Santero Therapeutics seeks to contribute to the fight against antibiotic resistance, a growing concern in modern medicine.

Intressa Vascular focuses on developing innovative solutions for cardiovascular conditions, particularly addressing aortic dissection. The company utilizes a proprietary braiding technology platform to create multilayer stents designed for next-generation endovascular treatments. These products assist physicians in effectively managing the serious impacts of aortic dissections, ultimately aiming to enhance patient outcomes while minimizing the risk of ischemic complications. By fostering a collaborative and constructive approach, Intressa Vascular is committed to advancing patient care through high-quality medical products.

Intressa Vascular focuses on developing innovative solutions for cardiovascular conditions, particularly addressing aortic dissection. The company utilizes a proprietary braiding technology platform to create multilayer stents designed for next-generation endovascular treatments. These products assist physicians in effectively managing the serious impacts of aortic dissections, ultimately aiming to enhance patient outcomes while minimizing the risk of ischemic complications. By fostering a collaborative and constructive approach, Intressa Vascular is committed to advancing patient care through high-quality medical products.

Univercells is a provider of biomanufacturing solutions focused on making biologics, including vaccines and therapeutics, more accessible and affordable. The company offers innovative technologies designed to reduce manufacturing costs significantly, achieving up to 90% savings on the cost of goods and over 75% in capital investment. Their approach utilizes single-use technologies and integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode. Univercells also provides a range of biomanufacturing services, including scale-X hydro, scale-X carbo, and NevoLine, along with integrated support such as equipment confirmation, facility design, and bioprocess excellence. This comprehensive offering aids cell and gene therapy manufacturers in scaling their operations from research and development to commercial production, ultimately addressing global health challenges.

BOTALYS is a company focused on harnessing the health benefits of medicinal plants while prioritizing environmental sustainability. By employing indoor precision farming techniques, BOTALYS cultivates potent botanicals under ultra-clean conditions, ensuring that they achieve their full health potential. The company operates one of the largest vertical farms in Europe, allowing for the optimization of growth environments that mimic natural wild conditions. BOTALYS is particularly known for developing a full-spectrum Korean red ginseng root powder, which is engineered to replicate the characteristics of a 20-year-old wild specimen. This dedication to quality and bioactivity enables BOTALYS to provide traceable and pure ingredients to emerging brands, thus advancing the understanding and application of botanical biodiversity in health products.

I-care Group is an industrial company based in Belgium that specializes in predictive and prescriptive maintenance services. Established in 2004, the company utilizes advanced technology to optimize industrial risk management and enhance operational performance across various dimensions. By offering artificial intelligence-powered solutions, I-care Group enables clients to effectively collect, connect, manage, and analyze industrial data. This approach helps predict failures in machinery and equipment, ultimately decreasing maintenance costs, increasing equipment uptime, and improving the overall reliability and safety of operations. With a commitment to high-quality service and integrated technology expertise, I-care Group supports clients in maintaining effective performance in their businesses while considering human and environmental impacts.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacturing of small satellites equipped with advanced sensors. The company focuses on addressing complex challenges through innovative solutions, including the use of artificial intelligence and machine learning to automate various tasks. Aerospacelab's technology enables the collection of high-resolution optical data and provides a platform that facilitates the analysis of large datasets. This capability allows customers to effectively survey and monitor diverse applications, optimizing the transformation of the information gathered.

EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition traditionally managed through daily eye drop administration. EyeD Pharma aims to enhance the quality of life for patients by creating therapies that reduce side effects associated with existing treatments. In collaboration with ophthalmologists, the company offers new treatment options and surgical products, helping to improve clinical practices and provide therapeutic assistance that is currently lacking in the market.

PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

Sortlist is an online platform designed to assist businesses in finding marketing and communication agencies that meet their specific needs. By utilizing a multi-criteria searching tool, Sortlist connects marketing managers with suitable partners quickly and efficiently, allowing them to focus on their core objectives. The platform is linked to professional networks and incorporates peer-to-peer recommendations, making the search process more effective for businesses of all sizes and sectors. With Sortlist, clients can streamline their search for service providers, ensuring they find the right match to achieve their marketing and communication goals.

Vertuoza is a developer of construction software that centralizes the management of construction sites and teams, enabling professionals to focus on the core aspects of their business. The platform allows users to streamline various tasks such as editing estimates, planning work schedules, monitoring site activities, and invoicing, all accessible from a single interface. By anticipating potential issues and providing solutions, Vertuoza enhances time management and efficiency for contractors. This software not only improves operational workflows but also enhances service delivery to clients and highlights projects for architects, establishing a beneficial relationship among all parties involved. Vertuoza embodies a philosophy of being both virtuous and virtuose, signifying its commitment to excellence in construction management.

ImCyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, that specializes in developing active immunotherapies aimed at treating and preventing severe chronic autoimmune diseases linked to immune system disruptions. Founded in 2010, ImCyse utilizes a unique technology platform that focuses on the administration of Imotopes™, specifically modified peptides that generate cytolytic CD4 T-cells. These T-cells selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, targeting the underlying causes of diseases like type 1 diabetes and multiple sclerosis. ImCyse's innovative approach not only aims to provide therapeutic alternatives where none exist but also seeks to cure patients without compromising their immune defenses. The company has demonstrated proof of concept across several indications and has successfully completed its first clinical trial for type 1 diabetes, yielding promising results while developing additional Imotopes™ for various autoimmune conditions.

Univercells is a provider of biomanufacturing solutions focused on making biologics, including vaccines and therapeutics, more accessible and affordable. The company offers innovative technologies designed to reduce manufacturing costs significantly, achieving up to 90% savings on the cost of goods and over 75% in capital investment. Their approach utilizes single-use technologies and integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode. Univercells also provides a range of biomanufacturing services, including scale-X hydro, scale-X carbo, and NevoLine, along with integrated support such as equipment confirmation, facility design, and bioprocess excellence. This comprehensive offering aids cell and gene therapy manufacturers in scaling their operations from research and development to commercial production, ultimately addressing global health challenges.

Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer’s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.

PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

BOTALYS is a company focused on harnessing the health benefits of medicinal plants while prioritizing environmental sustainability. By employing indoor precision farming techniques, BOTALYS cultivates potent botanicals under ultra-clean conditions, ensuring that they achieve their full health potential. The company operates one of the largest vertical farms in Europe, allowing for the optimization of growth environments that mimic natural wild conditions. BOTALYS is particularly known for developing a full-spectrum Korean red ginseng root powder, which is engineered to replicate the characteristics of a 20-year-old wild specimen. This dedication to quality and bioactivity enables BOTALYS to provide traceable and pure ingredients to emerging brands, thus advancing the understanding and application of botanical biodiversity in health products.

Odoo is an open-source platform that offers a comprehensive suite of integrated business applications aimed at managing various company operations. Its tools encompass customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. These applications are designed to work cohesively, facilitating seamless workflows across different departments within a business. Odoo enables organizations to automate processes and monitor activities from any device, thus enhancing efficiency and productivity in managing their operations.

EURA NOVA, founded in 2008, in the midst of the global economic turmoil is a privately-owned company that specializes in digital transformation through AI and data. They offer data consulting, develop custom data solutions (like their Digazu platform), conduct research into emerging technologies, and prioritize a strong, collaborative company culture.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

ImCyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, that specializes in developing active immunotherapies aimed at treating and preventing severe chronic autoimmune diseases linked to immune system disruptions. Founded in 2010, ImCyse utilizes a unique technology platform that focuses on the administration of Imotopes™, specifically modified peptides that generate cytolytic CD4 T-cells. These T-cells selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, targeting the underlying causes of diseases like type 1 diabetes and multiple sclerosis. ImCyse's innovative approach not only aims to provide therapeutic alternatives where none exist but also seeks to cure patients without compromising their immune defenses. The company has demonstrated proof of concept across several indications and has successfully completed its first clinical trial for type 1 diabetes, yielding promising results while developing additional Imotopes™ for various autoimmune conditions.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacturing of small satellites equipped with advanced sensors. The company focuses on addressing complex challenges through innovative solutions, including the use of artificial intelligence and machine learning to automate various tasks. Aerospacelab's technology enables the collection of high-resolution optical data and provides a platform that facilitates the analysis of large datasets. This capability allows customers to effectively survey and monitor diverse applications, optimizing the transformation of the information gathered.

Minoryx, they are committed to finding innovative treatments for life threatening rare diseases. They focus on pediatric diseases and they are currently working on treatments for neurometabolic diseases of genetic origin.Minoryx develops a new generation of small molecule drugs known as pharmacological chaperones, which offer the most promising approach to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved in repositioning-based projects.

Since 2009, VENYO has been working on a revolutionary B737NG Fixed Base Simulator (FBS) which was revealed and made its “World Premiere” at the Paris Air Show in 2013. It was the very first time that the aeronautical industry was able to view an innovative and fully functional flight simulator operated on site at Le Bourget. Being qualified as a “Game Changer” by the professional community not only confirmed but encouraged VENYO’s intention to continue to invest and move from concept to commercialization. As professionals in aviation training, we’ve understood that high-quality Fixed Base Simulators (FBS) like ours are now in demand to off-load training tasks at an unrivalled budget that would otherwise be done in an expensive Level D Full Flight Simulator (FFS). Designed from day one for the highest level of certification for a motionless training device, we are proud to provide a solution to the pilot shortage with a product allowing you to increase simulator training hours without extra costs. ‘Power-by-the-Hour’ rental model is as some may say a ‘disruptive’ approach to the market. Our flexible, monthly billing includes a minimal contractual number of hours or metered fees (if minimum is exceeded) at a predefined hourly rate. The idea is to offer a simulator at your premises which is constantly maintained to premier standards, with no hidden fees. Our goal is to offer more flexibility for the customer in terms of adjusting to the ongoing market changes in technology and training capacity. Our simulator is easy to install and to operate. It doesn’t require an empty FFS bay and a nuclear power plant nearby. Look at how one of our partners simply installed our training device in a maintenance hangar.

ChromaCure is engaged in the development of innovative cancer therapies, focusing on discovering first-in-class small molecule therapeutics to address unmet needs in oncology. The company is initiating a drug development program aimed at identifying new candidates that selectively and potently inhibit cancer targets. This initiative seeks to provide novel treatment options for multiple forms of cancer, either as standalone therapies or in combination with existing immunotherapy or chemotherapy approaches. Through its efforts, ChromaCure aims to enhance the therapeutic landscape for cancer patients, offering potential new solutions for various cancer types.

Epic Therapeutics is a drug discovery and development company focused on creating innovative therapeutic solutions for cancer through the field of RNA epigenetics. The company specializes in developing small molecule drugs that target RNA epigenetic mechanisms, utilizing techniques such as RNA modifications, epigenomics, and transcriptomics. This approach aims to provide life-changing therapies for cancer patients, enabling medical practitioners to offer more effective treatment options.

EcoPhos is a Belgian technology provider and leading producer of animal feed phosphates in Europe, headquartered in Louvain-La-Neuve. The company operates with a workforce of 250 employees and includes an engineering office and a demonstration unit. EcoPhos specializes in the manufacturing of inorganic feed phosphates through a process that purifies phosphoric acid and produces various phosphate salts. Its operations focus on delivering agricultural phosphate products that are free from toxic substances, thereby minimizing environmental impact. The company has two production sites with a combined capacity of 300,000 tons per annum, reinforcing its position in the market.

Invineo design and development of a "smart machine" for catering and hospitality professionals.

Air Belgium S.A., founded in 1979 and based in Mont-Saint-Guibert, Belgium, provides passenger air transportation services primarily between Brussels and Hong Kong. The airline specializes in offering quality, attractively priced intercontinental flights to selected markets in Asia. Its fleet is equipped with economy, premium, and business class seating options, catering to diverse passenger needs, including provisions for traveling with pets and children. Additionally, Air Belgium enhances the travel experience through onboard catering services, ensuring that passengers enjoy comfortable and pleasant journeys.

ZenTech is a biotechnology company focused on the diagnosis of diseases that manifest in early life stages, as well as chronic conditions affecting both children and adults. The company specializes in the development, production, and marketing of In-Vitro Diagnostics (IVD) kits tailored for newborn screening and pediatric applications. By providing non-invasive sampling methods, ZenTech enables healthcare professionals to efficiently diagnose and manage various health conditions in young patients. This commitment to innovative diagnostic solutions positions ZenTech as a key player in the biotechnology sector.

Synergia Medical is focused on developing and commercializing advanced neurostimulation devices, leveraging optoelectronics technology. The company has achieved ISO13485 certification and has developed an external neurostimulator for motorized amputee prostheses, alongside its first version of the NAOS platform. Synergia Medical specializes in creating MRI-safe, implantable neurostimulators designed for drug-resistant epilepsy, with potential applications in various other therapeutic areas. Its innovative approach replaces traditional wiring with fiber optics, utilizing photovoltaic cells to convert optical energy into electrical impulses. With a skilled team of thirteen professionals and support from private investors and public research grants, Synergia Medical is positioned for growth in the medical device industry.

Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer’s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.

Qualifio SA is a Belgium-based company founded in 2011 that operates a cloud-based SaaS platform designed to engage digital audiences and collect data. The platform allows users to create and publish interactive campaigns such as quizzes, polls, and contests across various channels, including websites, mobile apps, and social media. With over 40 different formats available, Qualifio enables businesses to effectively engage their audiences and gather valuable data for segmentation and analysis. The platform supports custom integrations, allowing clients to connect their existing customer relationship management (CRM) systems, data management platforms (DMP), and single sign-on (SSO) solutions. By providing a centralized approach to audience interaction and data collection, Qualifio helps brands enhance user engagement, increase registrations, and monetize their audience.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. The company leverages human induced pluripotent stem cell (hiPSC) technology to create predictive human cellular assay systems, which are used for safety and efficacy testing of drug candidates. Additionally, Ncardia enhances cardiovascular and neural drug screening, providing researchers and drug discovery companies with tools to better understand human disease biology. This approach aims to accelerate the overall drug discovery process, facilitating the development of safer and more effective therapeutic options.

International Drug Development Institute (IDDI) is an expert clinical trials service provider specialized in biostatistical and integrated eClinical services for pharmaceutical and biotechnology companies in several disease areas, including oncology and ophthalmology. IDDI optimizes the clinical development of drugs, biologics and devices thanks to proven statistical expertise and operational excellence.

Dim3 develops and markets innovative clinical expert platforms and medical devices. Our solutions speed up medical decisions, enhance the life of patients and reduce healthcare costs. Now on the market, DIM3 first platform focuses on the fight against disease-related malnutrition. This is a major but silent threat that costs lives and an estimated 170 billions euros/year for Europe only.

e-peas SA is a Belgian company that specializes in designing and manufacturing electronic systems that enable energy autonomy for Internet of Things (IoT) applications. Founded in 2014 and based in Mont-Saint-Guibert, the company develops energy harvesting solutions that allow IoT devices to draw power from their environment, including sources such as solar, thermal, vibration, and radiofrequency. e-peas produces energy harvesting power management integrated circuits (PMICs) and low-power microcontrollers that enhance the performance and longevity of batteries in connected devices. By facilitating the efficient use of ambient energy, e-peas aims to reduce the need for frequent battery replacements across various sectors, including home automation, healthcare, and agriculture. The company's innovations contribute to making IoT devices smarter and more energy-efficient, ultimately striving for a future where devices can operate indefinitely without traditional power sources.

Elium is a leading European knowledge-sharing solution that focuses on enhancing collaboration and knowledge management within organizations. The platform enables companies to capture, structure, and access vital information, thereby facilitating informed decision-making and fostering impactful outcomes. Elium functions as a corporate social network, allowing users to efficiently search for and share various types of information, which enhances the flow of knowledge both internally and externally. It integrates seamlessly with popular tools such as Microsoft SharePoint, Teams, G-Drive, Slack, and Workplace by Facebook, making it a versatile choice for knowledge-based organizations seeking to improve their team communications and collaboration efforts.

TConcept offers you the perfect brewing appliance, Teh®. This unique device will be launched on the market this year and will be able to provide extraordinary premium tea taste and olfactory sensation by respecting the infusion procedures. The ultimate tea experience. Fully automatic, their appliance provide to the tea an appropriate infusion vessel to enable tea leaves deliver their precious oils and ingredients. In its system, T-Concept has designed and developed a unique brewing apparatus where the internal part of the chamber (called the brewing vessel) is connected to the tea cartridge. Both are tightly sealed. The water is poured in the vessel and (being the cartridge sealed to it) gently flows into the capsule and prevent a thermal shock to raw material. Their brewing appliance has many capacities, including a recognition system by colors which allows him to select the appropriate temperature for each type of tea (each one of them possess her own color). It's also capable of performing an automatic rinsing and a capsule ejection, can display the brewing time, the temperature and the progress percentage for each brewing. And he can do it all with a contemporary design, giving you the feeling of meeting a real tea expert. Their capsules, with their special and transparent packaging, allow you too see the tea, his color and his ingredients and even smell all of his aromas and to make the perfect choice.

Performance for Assets SA is a Belgium-based company that specializes in developing software for machinery and operations management. The firm offers a data mining and analysis tool designed to assist companies in operations and maintenance by detecting warnings, identifying root causes of machinery failures, and analyzing machine behavior. Its solutions are tailored for industrial manufacturers and wind energy companies, providing a unique approach to optimize and manage process data related to rotating machines. By leveraging a collaborative analytical platform, Performance for Assets converts large data sets into actionable intelligence, enabling clients to effectively manage and enhance critical assets and production processes.

IONICS develops and supplies technologies and surface coatings especially for metal, glass and other substrates. Our customers are demanding and ambitious, they demand innovative technologies and a responsive service.

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Bodair offer you high quality connecting rods and advanced designs that deliver significant weight savings and far surpass the current designs of stainless steel or aluminum rods.

Quality Partner, established in 2000 as a spin-off from the University of Liège, specializes in food quality control measures, providing a range of services such as research, analyses, appraisals, audits, inspections, and certifications for food safety. With a team of over 75 professionals, the company conducts approximately 250,000 analyses and 15,000 audits annually across various sectors including agri-food, health, and the environment. Quality Partner is committed to delivering personalized, efficient, and cost-effective solutions that meet the highest industry standards. By integrating multidisciplinary expertise and focusing on client needs, the company aims to enhance quality systems and provide clear, actionable results that add value to its customers.

Françoise's Tartes makes simple, honest, homemade cakes and tarts.

Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Its primary product, the Genio system, is a user-centered, bilateral neurostimulation therapy that has received CE-Mark validation. OSA is a prevalent condition linked to significant health risks, including increased mortality and various comorbidities such as cardiovascular diseases, depression, and stroke. Nyxoah aims to address these critical health challenges through its advanced therapeutic offerings.

ISSOL is a manufacturer and developer specializing in active materials and glazing within the construction and glass industries. The company is committed to creating solutions that evoke emotion while aligning with the sustainable image requirements of its clients. By focusing on the green energy architectural sector, ISSOL develops positive energy applications that enable buildings to generate their own electricity from solar energy. This innovation supports architects globally in realizing iconic and environmentally friendly projects, contributing to a more sustainable future.

Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division

In conferences and debates, waiting for the wireless microphone in order to ask questions can be quite disruptive or even so slow that it ruins the flow of interactions. Keybate intends to solve this problem by turning the smartphones of every conference’s attendees into high-quality wireless microphones connected to every conference room's AV system. The app allows each attendee to request the floor and speak at the touch of a finger. The mobile app also allows attendees to send text questions, answer live polls, and interact with other attendees, either directly or through social networks. Keybate will be the essential companion for every conference attendee.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).

TSF BE design, manufacture, rental and sale of shooting, lighting, machinery and consumables for film and television.

Paprika is a privately held company that operates a chain of fashion stores focused on the plus-size and transitional-size womenswear market. The company offers a youthful and dynamic collection of apparel specifically designed for fashion-minded larger-sized women. Through its retail outlets and online store, Paprika aims to provide trendy clothing options that empower women with fuller figures to express their personal style without facing discrimination based on size.

Any-Shape is a company dedicated to Additive Technologies (3D printing) for industry with production capabilities including plastic, metal & composites materials.

Decube Group is a company based in Strépy-Bracquegnies, Belgium, specializing in technical and industrial services, including engineering, assembly, and industrial painting. The company focuses on providing solutions that help clients prevent corrosion and modify the surface of manufactured parts to achieve specific aesthetic and functional requirements. By offering a range of services under one roof, Decube enables its clients to streamline their operations and maintain the quality and appearance of their products.

Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural estrogen platform, E4 (Estetrol).

ChanvrEco S.A., founded in 2007 and based in Tinlot, Belgium, specializes in the manufacture of standard granulate derived from hemp straw, primarily for use in thermal and acoustic insulation. The company's flagship product, Prohemp, is an aggregate made from hemp that is specifically designed for building insulation applications. ChanvrEco serves the construction industry, contributing to sustainable building practices through its eco-friendly materials.

AMOS design and manufacture of very-high-accuracy optomechanical systems for the space industry and for professional astronomy. AMOS is active in three main areas: • Professional astronomy systems: telescopes, components and instrumentation for many of the world’s largest observatories. • Space systems: on-board installations for satellites, probes and space shuttles – telescopes, mirrors, mounts, frameworks and mechanisms. • Terrestrial satellite test equipment to validate satellites or payloads under space conditions prior to launch: vacuum chambers, thermal panels and ‘artificial stars’ (collimators).

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. The company leverages human induced pluripotent stem cell (hiPSC) technology to create predictive human cellular assay systems, which are used for safety and efficacy testing of drug candidates. Additionally, Ncardia enhances cardiovascular and neural drug screening, providing researchers and drug discovery companies with tools to better understand human disease biology. This approach aims to accelerate the overall drug discovery process, facilitating the development of safer and more effective therapeutic options.

Proxistore is a developer of a localized online advertising platform tailored for large retail chains and small businesses. Utilizing its patented geolocation search engine, Proxistore delivers targeted advertising across various devices, including mobile phones, tablets, and computers, as well as through web and in-app environments. This innovative approach allows merchants and store chains to enhance customer traffic and attract new clientele directly at their points of sale.

IBA engages in the distribution of crop protection and cattle feed products.

Lasea designs and manufactures industrial laser machines tailored for applications in various sectors, including medical, luxury, pharmaceutical, electronics, and automotive industries. The company specializes in femtosecond laser micromachining, providing services such as welding, marking, engraving, cutting, drilling, texturing, and thin film removal. By focusing on these advanced laser technologies, Lasea enables clients to utilize efficient and reliable solutions for their specific manufacturing needs.

Odoo is an open-source platform that offers a comprehensive suite of integrated business applications aimed at managing various company operations. Its tools encompass customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. These applications are designed to work cohesively, facilitating seamless workflows across different departments within a business. Odoo enables organizations to automate processes and monitor activities from any device, thus enhancing efficiency and productivity in managing their operations.

Pierret is a manufacturer specializing in exterior joinery, producing doors and windows made from PVC, aluminum, wood, and wood-aluminum. The company emphasizes quality and innovation, ensuring that its products meet the highest industry standards through rigorous research and development efforts. Pierret's doors and windows are fully customizable, offering features such as sound insulation and resistance to burglary, making them suitable for various customer needs. Additionally, the performance of these products, including their resistance to air, water, and wind, as well as their acoustic properties, is validated through testing in certified and independent laboratories.

Fruytier Group is a prominent player in the European softwood processing industry, involved in every stage of the timber supply chain, from sourcing round wood to delivering finished products. The company specializes in providing sawn wood for various applications, including structures, packaging, siding, and outdoor decking, primarily using Spruce and Douglas Fir sourced from local, sustainable timber resources. In addition to sawn wood, Fruytier Group supplies sawmill by-products such as pellets, sawdust, chips, and bark. Its services encompass sawing and grading, high-precision re-cutting, drying, planing, moulding, and treatment processes like dipping and high-pressure impregnation. Positioned in the heart of Europe, Fruytier Group efficiently processes over 1 million cubic meters of timber annually across its facilities in Belgium, Germany, and France, ensuring high-quality products with quick turnaround times for its partners in sectors such as prefabricated housing and retail.

Trendy Foods Belgium is a distribution of confectionery products.

iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.

Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.

ICARUS SA is a single source supplier of complete piping packages and manufacturer of specialty valves and tailor made products for onshore, offshore and subsea applications.

KitoZyme S.A. is a biotechnology company based in Herstal, Belgium, specializing in the development and production of biopolymers derived from non-animal sources, particularly chitosan and chitin-glucan. The company serves various markets, including nutraceuticals, cosmetics, beverages, and pharmaceuticals. In the nutraceutical sector, KitoZyme offers products such as KiOnutrime-Cs for weight management and KiOnutrime-CG for oxidative stress management. Its cosmetic line features KiOsmetine-CG, a multifunctional ingredient for skin care, and KiOsmetine-S, a plant-based alternative to silicone. For the beverage industry, KitoZyme provides KiOfine-CG, a fining agent for wines, and KiOfine-B, a processing aid for contaminant removal. In pharmaceuticals, it develops KiOmedine for applications in wound management and drug delivery systems. KitoZyme's commitment to innovation is supported by scientifically proven technologies, and it distributes its products through partners across multiple countries, including the United States and various European nations.

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

EURODV specializes in the design, manufacture, and installation of doors and partitions, including plain, glass, and high-performance metal options. The company focuses on providing door security technology tailored for the building and construction market. Its product offerings include steel doors, frames, and advanced options such as fireproof, anti-burglary, and bulletproof doors. By supplying these high-quality and innovative solutions, EURODV supports infrastructure companies in delivering superior products to their customers.

Spacebel is a company specializing in space systems and software engineering, focusing on applications in the space sector and earth observation. It serves a diverse clientele that includes space agencies, prime contractors, European institutions, and the commercial sector. The company develops a platform that facilitates mission definition, analysis, and the study of complete minisatellite systems. Its offerings encompass both onboard and ground segment products tailored for space observation and telecommunication applications. This enables clients to effectively monitor environmental conditions both on Earth and in space.

Iteos Therapeutics S.A. is a biotechnology company focused on developing immuno-oncology therapeutics to treat cancer patients. Headquartered in Gosselies, Belgium, the company was established in 2011 and operates as a subsidiary of Iteos Therapeutics, Inc. Its product pipeline features EOS-850, a small molecule antagonist targeting the adenosine A2a receptor, currently undergoing open-label Phase 1/2a clinical trials in adult patients. Another key candidate is EOS-448, an anti-TIGIT antibody, also in Phase 1/2a clinical trials. Iteos Therapeutics aims to address immune suppression in the tumor microenvironment by creating small molecule immunomodulators, thereby enhancing the effectiveness of existing cancer treatments and newer immunomodulatory therapies. The company leverages expertise from the Ludwig Cancer Research Institute in its efforts to advance cancer therapies.

GreenWatt is an established CleanTech company offering full engineering services, covering feasibility study conception, construction and starting up of turn key small scale biogas plants around innovative and unique patented technologies solving all key issues of anaerobic digestion.

Rentel is a Belgian knowledge centre for offshore wind energy that develops, finances, constructs and operates offshore wind parks in Belgian North Sea and possibly also abroad.

Eurogare sa is a design office specializing in the technical study, monitoring and implementation of railway and architectural projects: terminals and railway infrastructure, signal booths, infrastructure logistics centers, workshops, car parks, offices.

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Carmeuse is a global manufacturer specializing in lime, high-calcium limestone, and dolomitic stone, offering a diverse range of mineral-based products. The company serves various sectors, including chemical, agricultural, engineering, environmental, steel, glass, and ceramics industries. Carmeuse extracts and processes high-calcium limestone and dolomite into lime and lime-related products tailored to meet the specific needs of industrial and commercial customers. In addition to its production capabilities, Carmeuse provides customized equipment and engineering solutions for plant operations, storage, and product transfer, thereby helping clients optimize their processes, enhance safety, and reduce their carbon footprint.